Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Oral Anti-Diabetic Drug Market Analysis 2015-2019 and Forecast 2020-2025

  • 99S3755551
  • 100 Pages
  • February 2020
  • Healthcare
Download Sample    Get Discount   
 
Snapshot

The global Oral Anti-Diabetic Drug market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Oral Anti-Diabetic Drug by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Glimepiride

Gliclazide

Glyburide

Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

Takeda

Pfizer

Eli Lilly

Janssen Pharmaceuticals

Astellas

Boehringer Ingelheim

Merck And Co.

AstraZeneca

Bristol Myers Squibb

Novartis

Sanofi

Abbott

Biocon

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Hospital

Research Institual

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Table of Contents

1 Industry Overview

1.1 Oral Anti-Diabetic Drug Industry

Figure Oral Anti-Diabetic Drug Industry Chain Structure

1.1.1 Overview

1.1.2 Development of Oral Anti-Diabetic Drug

1.2 Market Segment

1.2.1 Upstream

Table Upstream Segment of Oral Anti-Diabetic Drug

1.2.2 Downstream

Table Application Segment of Oral Anti-Diabetic Drug

Table Global Oral Anti-Diabetic Drug Market 2015-2025, by Application, in USD Million

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Oral Anti-Diabetic Drug Market by Type

3.1 By Type

3.1.1 Glimepiride

Table Major Company List of Glimepiride

3.1.2 Gliclazide

Table Major Company List of Gliclazide

3.1.3 Glyburide

Table Major Company List of Glyburide

3.1.4 Others

Table Major Company List of Others

3.2 Market Size

Table Global Oral Anti-Diabetic Drug Market 2015-2019, by Type, in USD Million

Figure Global Oral Anti-Diabetic Drug Market Growth 2015-2019, by Type, in USD Million

Table Global Oral Anti-Diabetic Drug Market 2015-2019, by Type, in Volume

Figure Global Oral Anti-Diabetic Drug Market Growth 2015-2019, by Type, in Volume

3.3 Market Forecast

Table Global Oral Anti-Diabetic Drug Market Forecast 2020-2025, by Type, in USD Million

Table Global Oral Anti-Diabetic Drug Market Forecast 2020-2025, by Type, in Volume

4 Major Companies List

4.1 Takeda (Company Profile, Sales Data etc.)

4.1.1 Takeda Profile

Table Takeda Overview List

4.1.2 Takeda Products & Services

4.1.3 Takeda Business Operation Conditions

Table Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.2 Pfizer (Company Profile, Sales Data etc.)

4.2.1 Pfizer Profile

Table Pfizer Overview List

4.2.2 Pfizer Products & Services

4.2.3 Pfizer Business Operation Conditions

Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.3 Eli Lilly (Company Profile, Sales Data etc.)

4.3.1 Eli Lilly Profile

Table Eli Lilly Overview List

4.3.2 Eli Lilly Products & Services

4.3.3 Eli Lilly Business Operation Conditions

Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.4 Janssen Pharmaceuticals (Company Profile, Sales Data etc.)

4.4.1 Janssen Pharmaceuticals Profile

Table Janssen Pharmaceuticals Overview List

4.4.2 Janssen Pharmaceuticals Products & Services

4.4.3 Janssen Pharmaceuticals Business Operation Conditions

Table Business Operation of Janssen Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.5 Astellas (Company Profile, Sales Data etc.)

4.5.1 Astellas Profile

Table Astellas Overview List

4.5.2 Astellas Products & Services

4.5.3 Astellas Business Operation Conditions

Table Business Operation of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.6 Boehringer Ingelheim (Company Profile, Sales Data etc.)

4.6.1 Boehringer Ingelheim Profile

Table Boehringer Ingelheim Overview List

4.6.2 Boehringer Ingelheim Products & Services

4.6.3 Boehringer Ingelheim Business Operation Conditions

Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.7 Merck And Co. (Company Profile, Sales Data etc.)

4.7.1 Merck And Co. Profile

Table Merck And Co. Overview List

4.7.2 Merck And Co. Products & Services

4.7.3 Merck And Co. Business Operation Conditions

Table Business Operation of Merck And Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.8 AstraZeneca (Company Profile, Sales Data etc.)

4.8.1 AstraZeneca Profile

Table AstraZeneca Overview List

4.8.2 AstraZeneca Products & Services

4.8.3 AstraZeneca Business Operation Conditions

Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.9 Bristol Myers Squibb (Company Profile, Sales Data etc.)

4.9.1 Bristol Myers Squibb Profile

Table Bristol Myers Squibb Overview List

4.9.2 Bristol Myers Squibb Products & Services

4.9.3 Bristol Myers Squibb Business Operation Conditions

Table Business Operation of Bristol Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.10 Novartis (Company Profile, Sales Data etc.)

4.10.1 Novartis Profile

Table Novartis Overview List

4.10.2 Novartis Products & Services

4.10.3 Novartis Business Operation Conditions

Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.11 Sanofi (Company Profile, Sales Data etc.)

4.11.1 Sanofi Profile

Table Sanofi Overview List

4.11.2 Sanofi Products & Services

4.11.3 Sanofi Business Operation Conditions

Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.12 Abbott (Company Profile, Sales Data etc.)

4.12.1 Abbott Profile

Table Abbott Overview List

4.12.2 Abbott Products & Services

4.12.3 Abbott Business Operation Conditions

Table Business Operation of Abbott (Sales Revenue, Cost, Gross Margin)

4.13 Biocon (Company Profile, Sales Data etc.)

4.13.1 Biocon Profile

Table Biocon Overview List

4.13.2 Biocon Products & Services

4.13.3 Biocon Business Operation Conditions

Table Business Operation of Biocon (Sales Revenue, Cost, Gross Margin)

5 Market Competition

5.1 Company Competition

Table Global Oral Anti-Diabetic Drug Sales Revenue 2015-2019, by Company, in USD Million

Table Global Oral Anti-Diabetic Drug Sales Revenue Share 2015-2019, by Company, in USD Million

Figure Global Oral Anti-Diabetic Drug Sales Revenue Share in 2019, by Company, in USD Million

Table Global Oral Anti-Diabetic Drug Sales Volume 2015-2019, by Company, in Volume

Table Global Oral Anti-Diabetic Drug Sales Volume Share 2015-2019, by Company, in Volume

Figure Global Oral Anti-Diabetic Drug Sales Volume Share in 2019, by Company, in Volume

5.2 Regional Market by Company

Figure North America Oral Anti-Diabetic Drug Market Concentration, in 2019

Figure Europe Oral Anti-Diabetic Drug Market Market Concentration, in 2019

Figure Asia-Pacific Oral Anti-Diabetic Drug MMarket Concentration, in 2019

Figure South America Oral Anti-Diabetic Drug Market Concentration, in 2019

Figure Middle East & Africa Oral Anti-Diabetic Drug Market Concentration, in 2019

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Hospital

Figure Oral Anti-Diabetic Drug Demand in Hospital, 2015-2019, in USD Million

Figure Oral Anti-Diabetic Drug Demand in Hospital, 2015-2019, in Volume

6.1.2 Demand in Research Institual

Figure Oral Anti-Diabetic Drug Demand in Research Institual, 2015-2019, in USD Million

Figure Oral Anti-Diabetic Drug Demand in Research Institual, 2015-2019, in Volume

6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

6.3 Demand Forecast

Table Oral Anti-Diabetic Drug Demand Forecast 2020-2025, by Application, in USD Million

Figure Oral Anti-Diabetic Drug Market Growth 2020-2025, by Application, in USD Million

Figure Oral Anti-Diabetic Drug Market Share in 2025, by Application, in USD Million

Table Oral Anti-Diabetic Drug Demand Forecast 2020-2025, by Application, in Volume

Table Oral Anti-Diabetic Drug Market Growth 2020-2025, by Application, in Volume

Table Oral Anti-Diabetic Drug Market Share in 2025, by Application, in Volume

7 Region Operation

7.1 Regional Production

Table Oral Anti-Diabetic Drug Production 2015-2019, by Region, in USD Million

Table Oral Anti-Diabetic Drug Production 2015-2019, by Region, in Volume

7.2 Regional Market

Table Global Oral Anti-Diabetic Drug Market 2015-2019, by Region, in USD Million

Table Global Oral Anti-Diabetic Drug Market Share 2015-2019, by Region, in USD Million

Table Global Oral Anti-Diabetic Drug Market 2015-2019, by Region, in Volume

Table Global Oral Anti-Diabetic Drug Market Share 2015-2019, by Region, in Volume

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

Figure North America Oral Anti-Diabetic Drug Market Size and Growth 2015-2019, in USD Million

Figure North America Oral Anti-Diabetic Drug Market Size and Growth 2015-2019, in Volume

7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in USD Million

Table North America Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in Volume

7.3.2 Europe

7.3.2.1 Overview

Figure Europe Oral Anti-Diabetic Drug Market Size and Growth 2015-2019, in USD Million

Figure Europe Oral Anti-Diabetic Drug Market Size and Growth 2015-2019, in Volume

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in USD Million

Table Europe Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in Volume

7.3.3 Asia-Pacific

7.3.3.1 Overview

Figure Asia-Pacific Oral Anti-Diabetic Drug Market Size and Growth 2015-2019, in USD Million

Figure Asia-Pacific Oral Anti-Diabetic Drug Market Size and Growth 2015-2019, in Volume

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in Volume

7.3.4 South America

7.3.4.1 Overview

Figure South America Oral Anti-Diabetic Drug Market Size and Growth 2015-2019, in USD Million

Figure South America Oral Anti-Diabetic Drug Market Size and Growth 2015-2019, in Volume

7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in USD Million

Table South America Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in Volume

7.3.5 Middle East & Africa

7.3.5.1 Overview

Figure Middle East & Africa Oral Anti-Diabetic Drug Market Size and Growth 2015-2019, in USD Million

Figure Middle East & Africa Oral Anti-Diabetic Drug Market Size and Growth 2015-2019, in Volume

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in Volume

7.4 Regional Import & Export

7.5 Regional Forecast

Table Oral Anti-Diabetic Drug Market Forecast 2020-2025, by Region, in USD Million

Table Oral Anti-Diabetic Drug Market Forecast 2020-2025, by Region, in Volume

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

Table Price Factors List

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

Figure Marketing Channels Overview

9 Research Conclusion

List of Table

Table Upstream Segment of Oral Anti-Diabetic Drug

Table Application Segment of Oral Anti-Diabetic Drug

Table Global Oral Anti-Diabetic Drug Market 2015-2025, by Application, in USD Million

Table Major Company List of Gliclazide

Table Major Company List of Glyburide

Table Major Company List of Others

Table Global Oral Anti-Diabetic Drug Market 2015-2019, by Type, in USD Million

Table Global Oral Anti-Diabetic Drug Market 2015-2019, by Type, in Volume

Table Global Oral Anti-Diabetic Drug Market Forecast 2020-2025, by Type, in USD Million

Table Global Oral Anti-Diabetic Drug Market Forecast 2020-2025, by Type, in Volume

Table Takeda Overview List

Table Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Janssen Pharmaceuticals Overview List

Table Business Operation of Janssen Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Astellas Overview List

Table Business Operation of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Boehringer Ingelheim Overview List

Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck And Co. Overview List

Table Business Operation of Merck And Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bristol Myers Squibb Overview List

Table Business Operation of Bristol Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi Overview List

Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Abbott Overview List

Table Business Operation of Abbott (Sales Revenue, Cost, Gross Margin)

Table Biocon Overview List

Table Business Operation of Biocon (Sales Revenue, Cost, Gross Margin)

Table Global Oral Anti-Diabetic Drug Sales Revenue 2015-2019, by Company, in USD Million

Table Global Oral Anti-Diabetic Drug Sales Revenue Share 2015-2019, by Company, in USD Million

Table Global Oral Anti-Diabetic Drug Sales Volume 2015-2019, by Company, in Volume

Table Global Oral Anti-Diabetic Drug Sales Volume Share 2015-2019, by Company, in Volume

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Oral Anti-Diabetic Drug Demand Forecast 2020-2025, by Application, in USD Million

Table Oral Anti-Diabetic Drug Demand Forecast 2020-2025, by Application, in Volume

Table Oral Anti-Diabetic Drug Market Growth 2020-2025, by Application, in Volume

Table Oral Anti-Diabetic Drug Market Share in 2025, by Application, in Volume

Table Oral Anti-Diabetic Drug Production 2015-2019, by Region, in USD Million

Table Oral Anti-Diabetic Drug Production 2015-2019, by Region, in Volume

Table Global Oral Anti-Diabetic Drug Market 2015-2019, by Region, in USD Million

Table Global Oral Anti-Diabetic Drug Market Share 2015-2019, by Region, in USD Million

Table Global Oral Anti-Diabetic Drug Market 2015-2019, by Region, in Volume

Table Global Oral Anti-Diabetic Drug Market Share 2015-2019, by Region, in Volume

Table North America Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in USD Million

Table North America Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in Volume

Table Europe Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in USD Million

Table Europe Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in Volume

Table Asia-Pacific Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in Volume

Table South America Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in USD Million

Table South America Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in Volume

Table Middle East & Africa Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa Oral Anti-Diabetic Drug Market Size 2015-2019, by Country, in Volume

Table Oral Anti-Diabetic Drug Market Forecast 2020-2025, by Region, in USD Million

Table Oral Anti-Diabetic Drug Market Forecast 2020-2025, by Region, in Volume

Table Price Factors List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950